Depression and Anxiety Trial, Recruiting NCT05142384 Sponsor: Oregon Research Institute Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05142384
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Mothers who have scored 10 or above on a standard depression symptoms questionnaire (such as the PHQ or Edinburgh Postnatal Depression Scale), indicating elevated symptoms of depression
  • Mothers who have a child aged 2 to 5 years old who is enrolled in a participating Head Start program
  • Mothers who are able to communicate in English or Spanish
  • Children who are between 2 and 5 years old and enrolled in a participating Head Start program

Who may not be able to join:

  • Mothers who show signs of psychosis, another serious mental illness, or a cognitive disability that would make meaningful participation difficult (this may be identified during recruitment or reported by Head Start staff)
  • Mothers who have answered the highest-risk response on the suicide-related question of the depression questionnaire, indicating frequent thoughts of suicide — though the trial notes that these mothers may potentially be considered at a later time if that risk decreases (confirm with trial site)
  • There are no exclusion criteria listed for children

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Edward G Feil, Ph.D., Oregon Research Institute

Phone: 541-484-2123

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Oregon Research Institute
Registry
ClinicalTrials.gov
Start date
1 December 2022
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient Health Questionnaire-9 (PHQ-9); Maternal Acceptability (Modified System Usability Scale); Screening Reach (Reach); Implementation Reach (IReach); Maternal Engagement (Engage)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov